AirView
Cloud-based remote monitoring and patient management system for healthcare providers
Platform · Cloud SaaSCompany source
Company profile
About ResMed
ResMed is a pioneering medical technology company that develops cloud-connected medical devices and software solutions for people with sleep apnea, chronic obstructive pulmonary disease (COPD), and other chronic respiratory conditions. Founded in 1989, the company has grown into a global leader in sleep and respiratory care, serving millions of patients across more than 140 countries. ResMed's comprehensive portfolio includes continuous positive airway pressure (CPAP) devices, ventilators, masks, and digital health platforms that enable remote patient monitoring and care management. The company's technology approach combines advanced hardware engineering with cloud-based software and data analytics to deliver personalized therapy and improve patient outcomes. ResMed serves a diverse customer base including hospitals, sleep clinics, home medical equipment providers, and individual patients. Their solutions integrate with healthcare systems to provide clinicians with actionable insights and enable value-based care models. The company is committed to transforming care delivery through innovation in connected health, helping patients breathe easier, sleep better, and live healthier lives while reducing healthcare costs.
Company description ResMed official website
Primary marketChronic Disease Management & Digital Therapeutics
Commercial modelCommercial information available on request
Work at ResMed?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Asthma
- Chronic Respiratory Conditions
- COPD
- Sleep Apnea
Who it serves
- Health Systems
- Home Medical Equipment Providers
- Hospitals
- Payers
- Sleep Clinics
Deployment & integration
Cloud Saas · Embedded deployment with recorded integration context.
Geographic context
Markets140+ countries · Global
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
myAir
Patient engagement app for sleep apnea therapy tracking and coaching
Software · Cloud SaaSCompany source
ResMed CPAP Devices
Connected medical devices for sleep apnea and respiratory therapy
Device · EmbeddedCompany source
ResMed Digital Health Platform
Cloud-connected platform for remote patient monitoring and chronic disease management
Platform · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Derivation of evidence-based oral-to-parenteral uncertainty factors for medical device toxicological risk assessment.Regulatory toxicology and pharmacology : RTP · Sep 1, 2026
Positive Airway Pressure Therapy and Health Care Resource Use in Patients With OSA and Comorbid Insomnia.Chest · Jul 1, 2026
What do we know about the Epworth Sleepiness Scale in women? A review of the evidence.Sleep medicine reviews · Jun 15, 2026
Clinical profile of responders to adaptive servo-ventilation: a cluster analysis from the READ-ASV European cohort.Sleep medicine · Jun 13, 2026
Impact of Positive Airway Pressure Therapy on Health Care Resource Use in Patients With OSA and Coronary Artery Disease.Chest · Jun 1, 2026
Obstructive sleep apnea, positive airway pressure therapy, and COVID-19 outcomes.Sleep & breathing = Schlaf & Atmung · Apr 24, 2026
Clinical validation
Clinical-trial records
PAP-NAP Device Clinical StudyNCT07785310 · Sponsor · NOT YET RECRUITING
Exploration of Current and New Technologies for Accuracy of Diagnosing OSANCT07485582 · Sponsor · NOT YET RECRUITING
Long-term Observation of PAP-therapy With Telemonitoring: Telemedicine Registry TelePAPNCT03043716 · Sponsor · COMPLETED
HomeVent ( Connect) Registry: EU COPD Home NIV RegistryNCT02811588 · Sponsor · COMPLETED
Registry Study on Prescription, Patient Pathways, Therapy Efficacy and Usage of Mandibular Advancement Devices in Obstructive Sleep Apnea - PATT-OSA RegistryNCT03924817 · Sponsor · ACTIVE NOT RECRUITING
Regulatory
Regulatory records
Personalized Therapy Comfort Settings (PTCS)K251657 · 510k · Dec 5, 2025
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Improved therapy adherence
Connected care platforms
Reduced hospital readmissions
Remote patient monitoring for COPD
Better sleep quality
CPAP therapy optimization
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from ResMed
Recent articles published on ResMed's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Chronic Disease Management & Digital Therapeutics
Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.